Journals / KONURALP TIP DERGİSİ / 2023 / Cilt: 15 Sayı: 2

The results of liver transplantation performed in a single center due to hepatocellular carcinoma

Hepatosellüler kanser nedeniyle tek merkezde yapılan karaciğer nakli sonuçları

Pages
169–174
Publication Date
2023-06-22
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In patients diagnosed with HCC and undergoing liver transplantation; the gender being female and the classification method before transplantation affect life expectancy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Hepatocellular cancer (HCC) is the most common malignancy of the hepatobiliary system.
📊
Key Findings & Data:There are significant differences in the global spread of HCC.
💡
Conclusion & Impact:Conclusion: In patients diagnosed with HCC and undergoing liver transplantation; the gender being female and the classification method before transplantation affect life expectancy.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Transplantasyon · Karaciğer · Hepatosellüler kanser

Abstract

Objective: Hepatocellular cancer (HCC) is the most common malignancy of the hepatobiliary system. There are significant differences in the global spread of HCC. It is the major cause of death in patients with cirrhosis. Its molecular pathogenesis is highly complex and heterogeneous. Major risk factors for the development of HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection and alcohol-related liver cirrhosis. Hepatocellular cancer is rarely seen in the first 4 decades of life, except in communities where HBV infection is hyperendemic. Method: The study was conducted by retrospectively scanning the files of 204 patients diagnosed with HCC who applied to Organ Transplantation Center between 21.09.2014 and 13.04.2019. Patients were transplanted liver by being classified according to Milan criteria, San Francisco [University of California San Francisco (UCSF)] criteria, and Barcelona Clinic Liver Cancer (BCLC) criteria. Result: The median age of the patients was 58.03 (range 31 to 72). 170 of the patients were men and 34 of them were female. Liver transplantation was performed from cadaveric donors to 31 patients and from living donors to 173 patients. There is a significant relationship between the life span of the patients and their gender. Female patients have a longer life expectancy [t (202) = 2,963, p =, 003]. A significant relationship was found between life expectancy and surgical classification [F (3) = 3,008, (p =, 031)]. Conclusion: In patients diagnosed with HCC and undergoing liver transplantation; the gender being female and the classification method before transplantation affect life expectancy.

Özet

Amaç: Hepatosellüler kanser (HSK), hepatobiliyer sistemin en sık görülen malignitesidir. HSK'nin küresel yayılımında önemli farklılıklar vardır. Sirozlu hastalarda en önemli ölüm nedenidir. Moleküler patogenezi oldukça karmaşık ve heterojendir. HSK gelişimi için başlıca risk faktörleri kronik hepatit B virüsü (HBV) enfeksiyonu, kronik hepatit C virüsü (HCV) enfeksiyonu ve alkole bağlı karaciğer sirozudur. HSK, HBV enfeksiyonunun hiperendemik olduğu bölgeler dışında, genellikle hayatın ilk dört dekadı içerisinde görülmez. Metod: Çalışma, 21.09.2014-13.04.2019 tarihleri arasında organ nakli merkezine başvuran HSK tanılı 204 hastanın dosyaları geriye dönük olarak taranarak gerçekleştirildi. Hastalara Milan kriterlerine, San Francisco [University of California San Francisco (UCSF)] kriterlerine ve Barcelona Clinic Liver Cancer (BCLC) kriterlerine göre sınıflandırılarak karaciğer nakli yapıldı. Bulgular: Hastaların medyan yaşı 58.03 (31-72 aralığında) idi. Hastaların 170'i erkek, 34'ü kadındı. Kadavra vericisinden 31 hastaya, canlı vericiden ise 173 hastaya karaciğer nakli yapıldı. Hastaların yaşam süreleri ile cinsiyetleri arasında anlamlı bir ilişki olduğu görüldü. Kadın hastaların yaşam beklentisi daha uzundur [t (202) = 2.963, p =0.003]. Yaşam beklentisi ile cerrahi sınıflandırma arasında anlamlı bir ilişki bulundu [F (3) = 3.008, (p =0.031)]. Sonuç: HSK tanılı olup karaciğer nakli yapılan hastalarda; cinsiyetin kadın olması ve nakil öncesi yapılan sınıflandırma yöntemi, yaşam beklentisini etkilemektedir.

🔖

Cite This Article

ASLAN, S., YAZAR, Ş., KARGI, A., KURNAZ, E., ŞAHİN, D., PEKER, K., ASTARCİOGLU, I., POLAT, K. (2023). The results of liver transplantation performed in a single center due to hepatocellular carcinoma. KONURALP TIP DERGİSİ, Cilt: 15 Sayı: 2, 169–174. https://ajindex.com/articles/950194

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014
  2. 63(5):844-55. 2. Neuveut C, Wei Y, Buendia MA. Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol. 2010
  3. 52(4):594-604. 3. Guerrieri F, Belloni L, Pediconi N, Levrero M. Molecular mechanisms of HBV-associated hepatocarcinogenesis. Semin Liver Dis. 2013
  4. 33(2):147-56. 4. Mínguez B, Tovar V, Chiang D, Villanueva A, Llovet JM. Pathogenesis of hepatocellular carcinoma and molecular therapies. Curr Opin Gastroenterol. 2009
  5. 25(3):186-94. 5. Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma. Nat Rev Cancer. 2013
  6. 13(2):123-35. 6. Delis SG, Bakoyiannis A, Tassopoulos N, Athanassiou K, Kelekis D, Madariaga J, et al. Hepatic resection for hepatocellular carcinoma exceeding Milan criteria. Surg Oncol 2010
  7. 19(4):200-7. 7. Poon RT, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg. 2002
  8. 194(5):592-602. 8. Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, et al. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg. 2013
  9. 17(1):66-77. 9. Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010
  10. 30(1):61-74. 10 Lee KK, Kim DG, Moon IS, Lee MD, Park JH. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol. 2010
  11. 101(1):47-53. 11. Cauchy F, Fuks D, Belghiti J. HCC: current surgical treatment concepts. Langenbecks Arch Surg. 2012
  12. 397(5):681-95. 12. Giuliante F, Ardito F, Pinna AD, Sarno G, Giulini SM, Ercolani G, et al. Liver resection for hepatocellular carcinoma ≤3 cm: results of an Italian multicenter study on 588 patients. J Am Coll Surg. 2012
  13. 215(2):244-54. 13. Regimbeau JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti J. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery. 2002
  14. 131(3):311-7. 14. Kang CM, Choi GH, Kim DH, Choi SB, Kim KS, Choi JS, et al. Revisiting the role of nonanatomic resection of small ( 15. Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, et al. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas w